Farmax India Limited announced audited standalone and consolidated earnings results for the fourth quarter and year ended March 31, 2016. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 28.486 million against INR 79.760 million a year ago. Total income was INR 29.412 million against INR 95.089 million a year ago. Loss before interest and exceptional items was INR 5.557 million against INR 5.194 million a year ago. Loss before tax was INR 5.565 million against profit before tax of INR 46.811 million a year ago. Loss after tax was INR 5.565 million or INR 0.02 per basic and diluted share before and after extraordinary items against profit after tax of INR 46.811 million or INR 0.09 per basic and diluted share before and after extraordinary items a year ago. For the year, on standalone basis, the company reported net sales/income from operations of INR 164.116 million against INR 210.456 million a year ago. Total income was INR 166.973 million against INR 228.297 million a year ago. Loss before interest and exceptional items was INR 97.747 million against INR 20.410 million a year ago. Loss before tax was INR 97.813 million against INR 21.011 million a year ago. Loss after tax was INR 97.813 million or INR 0.18 per basic and diluted share before and after extraordinary items against INR 21.011 million or INR 0.04 per basic and diluted share before and after extraordinary items a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations of INR 28.486 million against INR 79.760 million a year ago. Total income was INR 29.412 million against INR 95.089 million a year ago. Loss before interest and exceptional items was INR 6.008 million against INR 5.194 million a year ago. Loss before tax was INR 6.016 million against profit before tax of INR 46.811 million a year ago. Loss after tax was INR 6.016 million or INR 0.02 per basic and diluted share before and after extraordinary items against profit after tax of INR 46.811 million or INR 0.09 per basic and diluted share before and after extraordinary items a year ago. For the year, on consolidated basis, the company reported net sales/income from operations of INR 164.116 million against INR 210.456 million a year ago. Total income was INR 166.973 million against INR 228.297 million a year ago. Loss before interest and exceptional items was INR 98.198 million against INR 20.834 million a year ago. Loss before tax was INR 98.264 million against INR 21.435 million a year ago. Loss after tax was INR 98.264 million or INR 0.18 per basic and diluted share before and after extraordinary items against INR 21.435 million or INR 0.04 per basic and diluted share before and after extraordinary items a year ago.